Neurology and Brain Disorders Economy: OMICS International Conference Series Improve Healthcare

Share Article

Specialists on Call - Advances in Neurology and Brain Care: OMICS Group Meetings

Conference Series Logo

Global Conference Series Logo

Conference Series organizes 3000 scientific meetings every year across America, Europe, Middle East and Asia

With great motivation and immense dedication approach towards human health progression and concerns, OMICS International is happy to announce Neuroscience Conferences global schedule for the year 2017.

Neurology is the branch that deals with the anatomy, function, diagnosis and treatment of disease and disorders that affect the central nervous system (which includes the brain and spinal cord). Neuroscience manages the determination and treatment of all classes of conditions and infection including the focal and fringe sensory system, veins, and all effectors tissue. Many scientists have asserted that neurological disorders are a serious threat to general wellbeing. Neuroscience medicine includes the study and treatment of various neurological disorders like Alzheimer’s disease, schizophrenia, major depressive disorder, Parkinson’s disease, migraine, epilepsy/seizures, bipolar disorder, insomnia/sleep disorders and ADHD.

Our Neurology conferences address the advances in the function, anatomy, diagnosis and treatment of diseases and disorders that have brought a significant breakthrough in the research field of various neurological disorders. Nearly 600 diseases of the nervous system acquired their importance in the research field of neuroscience, such as brain disorders, Alzheimer’s disease, Epilepsy, Parkinson's disease and Brain Stroke. The UK and USA are at the forefront of research in Neuroscience. Interesting areas have emerged in neuroscience research such as Neuro economics, Neural networks and Neuro marketing. Together, these factors make neuroscience one of the more exciting and opportunity packed fields. Today, every major market research company has neuroscience offerings.

Large investments were made. However, mental and neurologic disorders have cost the US economy more than $1.5 trillion, or 8.8% of total worldwide output (GDP).

Neurological disorders conferences are expected to accelerate from 95 million globally in 2015 to 103 million by 2030, and the same is reflected in global neuroscience market size growth at CAGR of 2.9%. It is estimated that globally 47.5 million people are with dementia, prevalence of migraine is more than 10% worldwide. Moreover, the worldwide cost of neurological squeal solitary estimated in 2010 was US$2.5 trillion and it is assumed that the value will spike to over US $6 trillion by 2030.

Glancing at Europe, the cost of Neurological diseases was reputed to be €798 billion, whereas in America it was estimated at more than $760 billion per year. Regionally, North America spiked up as the largest regional neuroscience market with contribution of 40.0%. The Asia Pacific industry for neurology conferences is estimated to grow at a Compound Annual Growth Rate of nearly 3.0% over the forecast period to reach revenue over USD 8.00 billion by 2020. The global market for Neuro marketing technology is expected to reach $22.0 million by 2021, increasing at a compound annual growth rate of 18.0% from 2016 to 2021. Altogether these values make clear about the contribution of Neurological disorders and diseases towards global burden and pinpoint the potentially boundless demand of Neuroscience Research.

Pharmaceutical drugs in Neurology are one in all riding fields in prescription as some distance as subsidizing and research. On pinnacle of developing patient numbers, there remains a surprisingly excessive unmet want in treatment of numerous neurological illnesses. With the functionality of being a standout amongst the most lucrative remedy zones later on pharmaceutical industry, Alzheimer's disease offers the first-rate business open door for pharmaceutical organizations in neurology.

Hundreds of millions of people worldwide are affected by neurological disorders and within that, tens of millions of Americans suffer from a variety of mental and neurological health conditions each year. According to a recent report, more than 50 million Americans - which includes about 21.8 percent of the adult population - have experienced a brain disease or disorder in the past year. This includes many neurodegenerative diseases such as Alzheimer’s and Parkinson’s, psychiatric disorders and autism. Around 6 million people were dying because of stroke every year. Over 80% of these deaths take place in low- and middle-income countries. More than 50 million people have epilepsy worldwide. It is essential to upgrade our insight on Current Research on Neurology and also on various neurosurgery techniques.

OMICS Group meetings with its 2000+ employees has been supported by 50000+ well-qualified scientists as editorial board members who serve on voluntary basis to disseminate healthcare and scientific information open access, and year on year this support is increasing progressively with which OMICS Group is able to grow from 10 peer reviewed journals in 2009 to 700 peer reviewed journals by 2016. OMICS Group open access journals and conferences readers/online visitors also increased from 10,000 in 2009 to 30 million by 2016. OMICS International Conference Series organizes 3000 scientific meetings every year across America, Europe, Middle East and Asia.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Issac Samuel

Valentina Cooper
@omicsgroupevent
Follow >
OMICS Group International Conferences
Like >
Follow us on
Visit website